Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Galmozzi

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|November 17, 2004
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipidsSilvia Arpicco, Silvana Canevari, Maurizio Ceruti, et al.
Journal of Cellular Physiology|May 12, 2004
HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNAEnrico Galmozzi, Patrizia Casalini, Marilena Valeria Iorio, et al.
Viral Immunology|April 18, 2018
Chemokine Receptor 5 Has No Major Role in the Severity of Hepatitis C Virus-Related Liver DamageGiuseppe Colucci, Roberta D'Ambrosio, Enrico Galmozzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2017
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patientsEnrico Galmozzi, Floriana Facchetti, Glenda Grossi, et al.
Journal of Viral Hepatitis|June 10, 2019
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antiviralsElisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, et al.
Cancer Research|February 5, 2003
The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinomaAntonella Tomassetti, Fabio Mangiarotti, Mimma Mazzi, et al.
Oncogene|October 19, 2002
p53-dependent downregulation of metastasis-associated laminin receptorMichele Modugno, Elda Tagliabue, Elena Ardini, et al.
Journal of Hepatology|September 6, 2017
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistanceGlenda Grossi, Alessandro Loglio, Floriana Facchetti, et al.
Plos One|April 25, 2014
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving TelaprevirAlessio Aghemo, Eleonora Grassi, Maria Grazia Rumi, et al.
Hepatology (Baltimore, Md.)|July 22, 2010
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver diseaseLuca Valenti, Anna Alisi, Enrico Galmozzi, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Farmaco (Societa Chimica Italiana : 1989)|November 17, 2004
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipidsSilvia Arpicco, Silvana Canevari, Maurizio Ceruti, et al.
Journal of Cellular Physiology|May 12, 2004
HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNAEnrico Galmozzi, Patrizia Casalini, Marilena Valeria Iorio, et al.
Viral Immunology|April 18, 2018
Chemokine Receptor 5 Has No Major Role in the Severity of Hepatitis C Virus-Related Liver DamageGiuseppe Colucci, Roberta D'Ambrosio, Enrico Galmozzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2017
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patientsEnrico Galmozzi, Floriana Facchetti, Glenda Grossi, et al.
Journal of Viral Hepatitis|June 10, 2019
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antiviralsElisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, et al.
Cancer Research|February 5, 2003
The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinomaAntonella Tomassetti, Fabio Mangiarotti, Mimma Mazzi, et al.
Oncogene|October 19, 2002
p53-dependent downregulation of metastasis-associated laminin receptorMichele Modugno, Elda Tagliabue, Elena Ardini, et al.
Journal of Hepatology|September 6, 2017
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistanceGlenda Grossi, Alessandro Loglio, Floriana Facchetti, et al.
Plos One|April 25, 2014
Limited utility of ITPA deficiency to predict early anemia in HCV patients with advanced fibrosis receiving TelaprevirAlessio Aghemo, Eleonora Grassi, Maria Grazia Rumi, et al.
Hepatology (Baltimore, Md.)|July 22, 2010
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver diseaseLuca Valenti, Anna Alisi, Enrico Galmozzi, et al.
Pageof 4